Tumors with the highest CD47 expression also had decreased numbers of FOXP3+ T-cells, resulting in a favorable cytotoxic to regulatory T-cell ratio post NACT in favor of anti-tumor immunity. The gene discussed is CD47; the disease is neoplasm.